Nebraska Statutes

§ 71-9602 — Terms, defined

Nebraska·Ch. 71 Public Health and Welfare

For purposes of the Investigational Drug Use Act:

(1)Advanced illness means any progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of federally approved and available treatments, and that, without life-sustaining procedures, would likely result in death within six months;
(2)Eligible patient means a person who meets the requirements of section 71-9603 ;
(3)Health care provider has the same meaning as in section 71-7907 ;
(4)Investigational drug, biological product, or device means any drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States

Free access — add to your briefcase to read the full text and ask questions with AI

Nebraska § 71-9602 (Terms, defined) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

Source: Laws 2018, LB117, § 2. Cross References: Medicine and Surgery Practice Act, see section 38-2001.

Nearby Sections

15
View on official source ↗